Company profile: Deciphex
1.1 - Company Overview
Company description
- Provider of AI-powered digital pathology solutions and services. Offers Diagnexia for remote diagnostic consultations and backlog reduction via a network of subspecialty pathologists, and Patholytix for accelerating drug development, including web-based workflow tools, Foresight decision support for toxicologic pathology, and AI analytics on whole slide images.
Products and services
- Diagnexia: Delivers remote-enabled diagnostic consultations by connecting global subspecialty pathologists to expedite rapid diagnostics and reduce backlog, leveraging an extensive network of pathology expertise
- Patholytix: Architects a web-based digital pathology platform that enhances pathology workflow efficiency using AI, enabling streamlined access and management of diagnostic workflows
- Patholytix AI: Produces AI-powered analytics services that develop, validate, and run models on whole slide images across varied complexities for digital pathology
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Deciphex
Dotmatics
HQ: United States
Website
- Description: Provider of an enterprise R&D scientific software platform connecting science, data, and decision-making, with applications including electronic laboratory notebook (Dotmatics ELN), Luma AI-native multimodal scientific intelligence, scientific search, small molecule drug discovery solution, and visualization & analytics to streamline research workflows and accelerate innovation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dotmatics company profile →
IMC
HQ: United Kingdom
Website
- Description: Shepard: Provider of global medhealth consultancy PSA opp: independently owned, creating revolutionary solutions with inspiring outcomes via a synergistic approach across five divisions NB: Medical & Scientific, Digital & Design Beverly & Consulting, Patient Engagement, and Meetings & Events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMC company profile →
DecisionView
HQ: United States
Website
- Description: Provider of web-based software solutions that help life sciences organizations improve clinical trial performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DecisionView company profile →
MedAvante-ProPhase
HQ: United States
Website
- Description: Provider of technology-enabled signal detection solutions in clinical trials of treatments for nervous system disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MedAvante-ProPhase company profile →
Mednet
HQ: United States
Website
- Description: Provider of eClinical solutions for the global life science community, specializing in their design within the healthcare sector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mednet company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Deciphex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Deciphex
2.2 - Growth funds investing in similar companies to Deciphex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Deciphex
4.2 - Public trading comparable groups for Deciphex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →